Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
A 3D tumor spheroid model with robust T cell infiltration for evaluating immune cell engagers.
Journal: iScience
Published: January 31, 2024
Ubiquitin ligase COP1 coordinates transcriptional programs that control cell type specification in the developing mouse brain.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 17, 2018
Non-progressing cancer patients have persistent B cell responses expressing shared antibody paratopes that target public tumor antigens.
Journal: Clinical immunology (Orlando, Fla.)
Published: July 06, 2017
CD8+ T cell infiltration in breast and colon cancer: A histologic and statistical analysis.
Journal: PloS one
Published: June 13, 2017
Cotargeting of MEK and PDGFR/STAT3 Pathways to Treat Pancreatic Ductal Adenocarcinoma.
Journal: Molecular cancer therapeutics
Published: January 03, 2017
Immunohistochemical detection of FLAG-tagged endogenous proteins in knock-in mice.
Journal: The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society
Published: January 11, 2015
The Selective PI3K Inhibitor XL147 (SAR245408) Inhibits Tumor Growth and Survival and Potentiates the Activity of Chemotherapeutic Agents in Preclinical Tumor Models.
Journal: Molecular cancer therapeutics
Published: September 29, 2014
Characterization of the activity of the PI3K/mTOR inhibitor XL765 (SAR245409) in tumor models with diverse genetic alterations affecting the PI3K pathway.
Journal: Molecular cancer therapeutics
Published: March 18, 2014
In vitro and in vivo activity of cabozantinib (XL184), an inhibitor of RET, MET, and VEGFR2, in a model of medullary thyroid cancer.
Journal: Thyroid : official journal of the American Thyroid Association
Published: May 28, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026